Ruth B. Schneider

Ruth B. Schneider, M.D., is an Associate Professor in the Department of Neurology at the University of Rochester School of Medicine and Dentistry. She serves as Director of the Huntington's Disease Society of America Center of Excellence and specializes in movement disorders including Parkinson's and Huntington's disease.

Education:

• MD, University of Rochester School of Medicine and Dentistry (2010)
• Neurology Residency, University of Rochester Medical Center (2011-2014)
• Movement Disorders Fellowship, University of Rochester Medical Center (2014-2015)

Research Focus: Dr. Schneider pioneers digital phenotyping and remote monitoring technologies for movement disorders. Her work integrates wearable sensors, AI-driven analysis, and participant-centered research designs to quantify disease progression and neuropsychiatric manifestations. She actively develops digital biomarkers for Parkinson's and Huntington's disease while addressing health equity in digital health adoption.

Publication Trends: Her recent work reveals a strong trajectory toward multimodal AI diagnostics and decentralized clinical trials. Key themes include remote Parkinson's screening, quantitative assessment of motor/cognitive symptoms, and ethical frameworks for digital health data. This research bridges neurology, engineering, and health services to transform movement disorder care.

Scientific Recognition:

• Women Leading in Neurology Program (2021-2022)

Research Leadership: As lead researcher for the Parkinson's Progression Markers Initiative (PPMI) 2.0, she directs a nationwide longitudinal study tracking digital and biological markers. Her work on the AT-HOME PD study established novel remote assessment protocols, while the SURE-PD3 trial investigated urate-elevating therapies. Current grants focus on environmental triggers (trichloroethylene) and digital health literacy.

Clinical Integration: Dr. Schneider co-leads UR Medicine's Movement Disorders Clinic and collaborates with the Center for Health and Technology to implement telemedicine innovations. Her team develops home-based monitoring systems using radio waves and smartphone sensors, directly translating research into patient care pathways.